These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16627519)

  • 41. Summaries for patients. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?
    Ann Intern Med; 2002 Jul; 137(1):I38. PubMed ID: 12093264
    [No Abstract]   [Full Text] [Related]  

  • 42. Attrition, missing data, compliance, and related biases in randomized controlled trials of rehabilitation interventions: towards improving reporting and conduct.
    Armijo-Olivo S; Machalicek W; DE Oliveira-Souza AI; Dennett L; Ballenberger N
    Eur J Phys Rehabil Med; 2020 Dec; 56(6):817-828. PubMed ID: 33165311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomised controlled trials may have many unrecognised potential biases.
    Hawkes N
    BMJ; 2018 Apr; 361():k1561. PubMed ID: 29622530
    [No Abstract]   [Full Text] [Related]  

  • 44. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.
    Akl EA; Briel M; You JJ; Sun X; Johnston BC; Busse JW; Mulla S; Lamontagne F; Bassler D; Vera C; Alshurafa M; Katsios CM; Zhou Q; Cukierman-Yaffe T; Gangji A; Mills EJ; Walter SD; Cook DJ; Schünemann HJ; Altman DG; Guyatt GH
    BMJ; 2012 May; 344():e2809. PubMed ID: 22611167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Problems in the conduct of a randomised clinical trial.
    ter Riet G; Kessels AG; Knipschild P
    J Wound Care; 1998 May; 7(5):259-62. PubMed ID: 9677998
    [No Abstract]   [Full Text] [Related]  

  • 46. Non-inferiority study design: lessons to be learned from cardiovascular trials.
    Head SJ; Kaul S; Bogers AJ; Kappetein AP
    Eur Heart J; 2012 Jun; 33(11):1318-24. PubMed ID: 22564354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 48. Compliance of Randomized Controlled Trials Published in General Surgical Journals With the CONSORT 2010 Statement.
    Limb C; White A; Fielding A; Lunt A; Borrelli MR; Alsafi Z; Schembri M; Fowler AJ; Agha RA
    Ann Surg; 2019 Mar; 269(3):e25-e27. PubMed ID: 29266005
    [No Abstract]   [Full Text] [Related]  

  • 49. 'Recruitment, recruitment, recruitment' - the need for more focus on retention: a qualitative study of five trials.
    Daykin A; Clement C; Gamble C; Kearney A; Blazeby J; Clarke M; Lane JA; Shaw A
    Trials; 2018 Jan; 19(1):76. PubMed ID: 29378618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statistics notes: missing outcomes in randomised trials.
    Vickers AJ; Altman DG
    BMJ; 2013 Jun; 346():f3438. PubMed ID: 23744649
    [No Abstract]   [Full Text] [Related]  

  • 51. Statistical reanalysis of a randomized trial of acupuncture for pain reveals positive effects as well as adverse treatment interactions on pain, attrition, and mortality.
    Shiflett SC; Schwartz GE
    Explore (NY); 2010; 6(4):246-55. PubMed ID: 20633839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mega-trials: methodological issues and clinical implications.
    Charlton BG
    J R Coll Physicians Lond; 1995; 29(2):96-100. PubMed ID: 7595900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.
    Hannan EL
    JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blinding during data analysis and writing of manuscripts.
    Gøtzsche PC
    Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
    [No Abstract]   [Full Text] [Related]  

  • 55. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes.
    Ibrahim F; Tom BD; Scott DL; Prevost AT
    Trials; 2016 Jun; 17(1):272. PubMed ID: 27255212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic survey of the methods literature on the reporting quality and optimal methods of handling participants with missing outcome data for continuous outcomes in randomized controlled trials.
    Zhang Y; Alyass A; Vanniyasingam T; Sadeghirad B; Flórez ID; Pichika SC; Kennedy SA; Abdulkarimova U; Zhang Y; Iljon T; Morgano GP; Colunga Lozano LE; Aloweni FAB; Lopes LC; Yepes-Nuñez JJ; Fei Y; Wang L; Kahale LA; Meyre D; Akl EA; Thabane L; Guyatt GH
    J Clin Epidemiol; 2017 Aug; 88():67-80. PubMed ID: 28579378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placebo group needed for interpretation of combination trial.
    El-Mallakh RS; Kaur G; Lippman S
    Am J Psychiatry; 2010 Aug; 167(8):996; author reply 996-7. PubMed ID: 20693473
    [No Abstract]   [Full Text] [Related]  

  • 58. Separation of health and statistics.
    Church TR
    J Natl Cancer Inst; 2008 Apr; 100(7):452-3. PubMed ID: 18364500
    [No Abstract]   [Full Text] [Related]  

  • 59. Sample size determination and statistical power in randomized controlled trials.
    Sjögren P; Hedström L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528
    [No Abstract]   [Full Text] [Related]  

  • 60. Trimmed means for symptom trials with dropouts.
    Permutt T; Li F
    Pharm Stat; 2017 Jan; 16(1):20-28. PubMed ID: 27523396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.